Magnus Pfahl, Ph.D.
| Maxia Pharmaceuticals | # of Grants: 1 |
Grants
| Analysis of Retinoid Mediated Anti-cancer Activities | 1993 (Cycle 2) | $757,415 |
| Cancer | Research Project Awards | |
Publications
| Inhibition of estrogen receptor activity by the tumor promoter 12-O-Tetradeconylphorbol-13-Acetate: a molecular analysis | ||||
| Periodical: Molecular Endocrinology | Index Medicus: | |||
| Authors: Tzukerman M, Zhang XK, Pfahl M | ART | |||
| Yr: 1991 | Vol: 5 | Nbr: 12 | Abs: | Pg: 1983-1992 |
| Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors | ||||
| Periodical: Nature | Index Medicus: | |||
| Authors: Zhang XK, Hoffmann B, Tran PB, Graupner G, Pfahl M | ART | |||
| Yr: 1992 | Vol: 355 | Nbr: 6359 | Abs: | Pg: 441-446 |
| Heterodimeric receptor complexes determine T3 and retinoid signaling specificities | ||||
| Periodical: Molecular Endocrinology | Index Medicus: | |||
| Authors: Hermann T, Hoffmann B, Zhang X-K, Tran P, Pfahl M | ART | |||
| Yr: 1992 | Vol: 6 | Nbr: 7 | Abs: | Pg: 1153-1162 |
| RARs and RXRalpha down-regulate the TGFbeta1 promoter by antagonizing AP-1 activity | ||||
| Periodical: Molecular Endocrinology | Index Medicus: | |||
| Authors: Salbert G, Fanjul A, Piedrafita FJ, et al | ART | |||
| Yr: 1993 | Vol: 7 | Nbr: 10 | Abs: | Pg: 1347-1356 |
| A novel class of retinoids with selective anti-AP-1 activity exhibit anti-proliferative activity | ||||
| Periodical: Nature | Index Medicus: | |||
| Authors: Fanjul A, Hobbs P, Graupner G, Zhang X-K, Dawson MI, Pfahl M | ART | |||
| Yr: 1994 | Vol: | Nbr: | Abs: | Pg: |
| Inhibition of estrogen receptor activity by the tumor promoter 12-O-Tetradeconylphorbol-13-Acetate: a molecular analysis | ||||
| Periodical: Molecular Endocrinology | Index Medicus: | |||
| Authors: Tzukerman M, Zhang XK, Pfahl M | ART | |||
| Yr: 1991 | Vol: 5 | Nbr: 12 | Abs: | Pg: 1983-1992 |
| Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors | ||||
| Periodical: Nature | Index Medicus: | |||
| Authors: Zhang XK, Hoffmann B, Tran PB, Graupner G, Pfahl M | ART | |||
| Yr: 1992 | Vol: 355 | Nbr: 6359 | Abs: | Pg: 441-446 |
| Heterodimeric receptor complexes determine T3 and retinoid signaling specificities | ||||
| Periodical: Molecular Endocrinology | Index Medicus: | |||
| Authors: Hermann T, Hoffmann B, Zhang X-K, Tran P, Pfahl M | ART | |||
| Yr: 1992 | Vol: 6 | Nbr: 7 | Abs: | Pg: 1153-1162 |
| RARs and RXRalpha down-regulate the TGFbeta1 promoter by antagonizing AP-1 activity | ||||
| Periodical: Molecular Endocrinology | Index Medicus: | |||
| Authors: Salbert G, Fanjul A, Piedrafita FJ, et al | ART | |||
| Yr: 1993 | Vol: 7 | Nbr: 10 | Abs: | Pg: 1347-1356 |
| A novel class of retinoids with selective anti-AP-1 activity exhibit anti-proliferative activity | ||||
| Periodical: Nature | Index Medicus: | |||
| Authors: Fanjul A, Hobbs P, Graupner G, Zhang X-K, Dawson MI, Pfahl M | ART | |||
| Yr: 1994 | Vol: | Nbr: | Abs: | Pg: |